Immunos is a Switzerland-based biotechnology company that develops and commercializes therapeutics for the treatment of cancer and autoimmune diseases... Read more
Immunos is a Switzerland-based biotechnology company that develops and commercializes therapeutics for the treatment of cancer and autoimmune diseases... Read more
News
Oct 20, 2025
GlobalNewswire
Press Release: ImmunOs : ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors
Aug 15, 2024
Startupticker
ImmunOs: Clinical advancements at ImmunOs Therapeutics and Noema Pharma
Jul 24, 2024
StreetInsider
Press Release: ImmunOs : ImmunOs Therapeutics Expands Phase I Clinical Trial of IOS-1002 in Combination with KEYTRUDA (pembrolizumab) for the Treatment of Solid Tumors
Dec 11, 2023
Vietnam Insider
ImmunOs: ImmunOs Therapeutics Presents Details of Novel Bispecific Anti-Tumor Molecules at ESMO Immuno-Oncology Congress 2023
Oct 24, 2023
StreetInsider
Press Release: ImmunOs : ImmunOs Therapeutics Presents Overview of Phase 1a/b Trial of Lead Compound IOS-1002
Oct 17, 2023
MarketScreener
ImmunOs: Gimv : ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA
May 25, 2023
Pharmabiz
ImmunOs: ImmunOs Therapeutics begins patient dosing in in phase 1 trial of lead compound IOS1002
Apr 25, 2023
Yahoo
ImmunOs: ImmunOs Therapeutics Appoints Michael A. Curran, PhD, as Chairman of its Scientific Advisory Board
Apr 14, 2023
Pharmabiz
ImmunOs: ProBioGen, ImmunOs Therapeutics team up to deliver innovative therapy for cancer patients
Apr 13, 2023
Contract Pharma
ImmunOs: ProBioGen, ImmunOs Therapeutics Extend Clinical Mfg. Pact
